The Nuclear Crash Narrative Is Wrong — Oklo and NuScale Are Not Cameco

I always keep an eye out for irrational false narratives that frequently take the stock market by storm and lead to some terrific bargains — but also to some terrific duds. The current headline sweeping the nuclear complex fits the second category perfectly.

The narrative goes like this: nuclear stocks are down 44% to 82%, this is a crash, and the dip-buying reflex should kick in. The problem with that framing is that it treats a speculative startup burning $150 million a year in free cash flow with zero revenue as the same asset class as a uranium miner generating $405 million in free cash flow and paying an 18-year dividend streak. It's not just inaccurate — in my opinion, it's irresponsible.

The nuclear complex has a split personality. The speculative end and the productive end are moving in opposite directions, and conflating them is a recipe for allocating capital into companies that may never make a dollar of electricity revenue.

Let's start with the companies the "wipeout" narrative is really about.

Oklo (OKLO) is the poster child for this story. The stock is down 41% year-to-date, trading at $42 after a 52-week high of $193.84 — a 78% drawdown from its peak. Oklo holds $1.6 billion in cash. Its trailing free cash flow is negative $153.5 million. At an ~$8 billion market cap, that's a pre-revenue company priced as if its commercial success is already assured.

NuScale Power (SMR) is worse. The stock is down 33% year-to-date and 84% from its 52-week high of $57.42, trading at $9.47. NuScale's trailing free cash flow is negative $778.8 million. Its cash balance is $766.5 million.

That being the case, NuScale is not a nuclear stock that "fell." It's a pre-commercial project company whose balance sheet and timeline have deteriorated materially — structural red flags, not a "dip."

Now let's look at the part of the nuclear complex the "wipeout" narrative conveniently ignores: the companies that actually produce uranium and generate cash.

Cameco (CCJ), the world's largest publicly traded uranium company, is up 2.3% year-to-date and trading at $93.62 against a 52-week range of $69 to $135. Cameco's trailing free cash flow is $405.1 million, its operating cash flow is $681.3 million, and it carries $783 million in cash against $2.2 billion in debt — leaving it with a net cash position of roughly $82 million. It has an 18-year consecutive dividend history and a trailing payout ratio of 29%. Its gross margin is 26.8%, operating margin is 14.8%, and it generates free cash flow at a 16.3% margin.

Cameco is not crashing. It is not down 44% to 82%. It is a profitable, cash-generating company whose stock pulled back from extreme 2025 highs — and whose valuation, while not cheap at a trailing P/E of 161x, reflects the structural tightening in uranium supply that has been unfolding for years. Thirty-eight countries pledged to triple nuclear capacity at last year's summit. The supply-demand imbalance in physical uranium is real and structural, not cyclical.

Centrus Energy (LEU) falls into an awkward middle ground. The stock is down 26.7% year-to-date and 62% from its 52-week high, trading at $178. Centrus has negative free cash flow of $61.4 million TTM and no dividend. It carries $1.9 billion in cash against $1.7 billion in debt. Its valuation is hard to assess — a forward P/E of 31.7x and an EV/EBITDA of 98.7x suggest the market has baked in substantial future revenue growth from its enrichment operations. Centrus is further along than Oklo or NuScale in commercial operations, but it's not a cash cow either.

Here's what the "nuclear wipeout" narrative gets wrong, and why it matters for how you allocate capital:

The first pillar of the false narrative is uniformity. It treats five nuclear-adjacent stocks as a single sector crash. In reality, Oklo and NuScale are pre-revenue project companies with no operating history, massive losses, and long regulatory timelines. Cameco is a mature mining business producing physical uranium with strong free cash flow. Centrus is a development-stage enrichment company with revenue but negative cash flow. Lumping them together and calling it a "buy the dip" opportunity is like calling oil majors, frac sand suppliers, and a Houston drill startup "energy stocks" and buying them all on the same dip.

The second pillar is the assumption that AI data center demand automatically benefits every company with "nuclear" in its name. AI-driven electricity demand is real. U.S. energy demand is expected to rise sharply through 2030. But Oklo's first commercial powerhouse won't deliver grid power for years. Meanwhile, Cameco is producing uranium today that reactors need today. The near-term beneficiaries of any energy demand surge are companies with current production and cash flow, not those with PowerPoint presentations and regulatory deadlines.

The third pillar is the dividend blindness. The "nuclear crash" narrative makes no mention of dividends because two of its five stocks pay none, one pays nothing, and the fourth (Cameco) pays a modest 0.18% yield. That omission tells you everything. If the thesis were about value and income, Cameco's 18-year dividend streak and 29% payout ratio would be the headline. The fact that they aren't suggests the article is fishing for volume, not conviction.

So what do I believe?

Of the companies this narrative conflates, I favor Cameco for its free cash flow generation, dividend commitment, and exposure to a structural uranium supply deficit. Cameco is a Hold at current levels — its forward P/E of 71x is rich, and the 2025 run-up was extraordinary — but it's a fundamentally different asset from Oklo and NuScale. It generates cash today, returns capital to shareholders, and operates in a physical commodity market where the supply-demand gap is narrowing, not widening.

Oklo and NuScale, in my opinion, are speculative venture bets disguised as public equities. Oklo has the benefit of stronger strategic partnerships — Meta, Nvidia, and Sam Altman's backing — and a clearer, if still distant, path to revenue. NuScale is worse, with a cash balance of $766.5 million that makes it a countdown clock, not a moat.

For investors who can tolerate the volatility and want long-dated exposure to nuclear infrastructure buildout, Oklo has the stronger partner ecosystem and a more credible regulatory path. For anyone seeking actual returns — dividends, free cash flow, a balance sheet that isn't a burn ledger — Cameco is the only name in this group that operates like a business rather than a prospectus.

The nuclear crash narrative is a false narrative because it pretends the entire complex moved the same way for the same reasons. The data says otherwise. Oklo and NuScale crashed because momentum faded on pre-revenue companies with long timelines. Cameco didn't crash — it pulled back from an extended rally while continuing to mine uranium and print cash. Treat them accordingly.